title: Reply: dissociating angiotensin 1-9 anticardiovascular remodeling effects from those on blood pressure.
authors.affiliation: aDivisión de Enfermedades Cardiovasculares, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile bMillennium Institute of Immunology and Immunotherapy cInstituto de Ciencias Biomedicas, Facultad de Medicina dAdvanced Center for Chronic Diseases (ACCDiS) and Centro Estudios Moleculares de la Celula, Facultad Ciencias Quimicas y Farmaceuticas and Facultad Medicina, Universidad de Chile, Santiago, Chile eCardiology Division, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
authors.forename: Maria Paz
authors.initials: MP
authors.lastname: Ocaranza
authors.forename: Luis
authors.initials: L
authors.lastname: Michea
authors.forename: Mario
authors.initials: M
authors.lastname: Chiong
authors.forename: Sergio
authors.initials: S
authors.lastname: Lavandero
authors.forename: Jorge E
authors.initials: JE
authors.lastname: Jalil
mesh_terms: D000803:Angiotensin I / Q000737:chemistry*; D000804:Angiotensin II / Q000737:chemistry*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000737:chemistry*; D000818:Animals; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D010446:Peptide Fragments / Q000737:chemistry*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D010446:Peptide Fragments; D000804:Angiotensin II; D000803:Angiotensin I